Trials / Completed
CompletedNCT03508323
Tenelia Elderly CGMS Study(TEDDY)
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase IV Study to Evaluate the Efficacy and Safety of Tenelia® in Patients Aged 65 and Older With Inadequately Controlled Type 2 Diabetes
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Handok Inc. · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
To assess the efficacy and safety of Teneligliptin in Patients aged 65 and Older with inadequately controlled type 2 diabetes.
Detailed description
To assess the efficacy and safety of Teneligliptin in Patients aged 65 and Older with inadequately controlled type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Teneligliptin | 20mg/qd |
| DRUG | Placebo | 1T/qd |
Timeline
- Start date
- 2018-04-03
- Primary completion
- 2019-12-12
- Completion
- 2019-12-12
- First posted
- 2018-04-25
- Last updated
- 2022-06-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03508323. Inclusion in this directory is not an endorsement.